Oddity is now down almost ~85% from its 2025 highs as Meta-driven ad costs spike, resulting in a cheap valuation. Read why I rate ODD stock a buy.

Novo Nordisk’s post-trial sell-off may be overdone. Click here for this comparative analysis of NVO and LLY stocks and see their valuation vs. realistic growth.

By that time, Davy Kirkpatrick said, we were sneaking to 200 billion rows in the table of all of our individual detections we had made in the last ten years. The field of engineering usually ...

A suburban misfit turned boredom, thrift store hunts and an M83 album cover into a blueprint for global coolness.